Inclusion Criteria:
  1. Signed informed consent
  2. Advanced cancers
  3. Immune checkpoint inhibitor therapy initiated within +/- 2wks
  4. Age >18y
  5. ECOG 0-3
  6. Patient compliant with the study procedures
Exclusion Criteria:
  1. Immune checkpoint inhibitor therapy initiated > 2wks ago
  2. General vulnerability affecting the participation in the trial
  3. No internet access